Veld Pharmaceuticals

Veld Pharmaceuticals operates as a one-stop solution organization for rare diseases and orphan products in Africa. Named after the diverse African grasslands of southern Africa, the company believes that the opportunities and needs for therapies addressing rare and debilitating diseases in Africa parallel the uniqueness of the region's grasslands. The goal of Veld Pharmaceuticals is to establish partnerships with innovators around the world, facilitating access to these medicines for the people of Africa and improving the lives of those suffering from rare diseases, as well as oncological and hematological disorders.

African Subcontinent Veld
African Subcontinent Veld

Alliance Members

background
CTS cts
background
EffRx Pharmaceuticals effrx
background
Medis medis
background
Innovative Medicines Group
background
Orpharm orpharm
background
Path Pharma path pharma
background
Vector Pharma vector-pharma
background
Specialised Therapeutics
background
Veld Pharmaceuticals Veld
background
Nxera Pharma
background
Theratechnologies

Territories

We offer a single entry point for our partners with orphan portfolios in ANZSEA, Canada, CEE, LATAM, MENAT, Cyprus, Greece, Israel, Japan and South Korea, Malta, Subcontinental Africa, Russia and CIS, and Switzerland.

Together we can achieve more.

With deep understanding of local healthcare systems, we can support our partners to expand their business throughout the complex WODA regions.

Contact us